Transcription‐Replication Conflicts: Unlocking New Frontiers in Cancer
BioEssays · 2025-08 · 47 (8)
DOI: 10.1002/bies.70025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioEssays, online erschienen am 09.06.2025. Verfasst von Aleix Bayona-Feliu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Microbiology and Statistics, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Neoplasms, DNA Replication, Genomic Instability, Transcription, Genetic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Genome instability (GIN) is a cell pathology linked to cancer promotion and tumor evolution. Transcription is an essential cellular process but also a potential source of DNA damage and GIN. Transcription‐replication conflicts (TRCs) are a predominant source of GIN, and defective TRC resolution may seriously compromise genome integrity. Importantly, chromatin dynamics helps orchestrate the response to TRCs to preserve genome integrity. Multiple epigenetic deficiencies have been shown to cause transcription‐induced replication stress, resulting in DNA breaks and mutations. Consistently, chromatin alterations are frequent in cancer and correlate with increased mutation burden at TRC sites in tumors. Here, we review our current knowledge of TRC processing, the consequences of its dysfunction, and its relevance in cancer. We focus on the interplay between the DNA damage response (DDR) and chromatin dynamics and discuss the clinical potential of targeting TRCs as anticancer strategies and drugging the associated epigenetic signatures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Microbiology and Statistics, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain.
- Centro Andaluz de Biología Molecular y Medicina Regenerativa CABIMER, Universidad de Sevilla, Seville, Spain.
- Departamento de Genética, Facultad de Biología, Universidad de Sevilla, Seville, Spain.
ORCID-Profile: Aleix Bayona-Feliu, Andrés Aguilera
Zitieren
APA
Bayona-Feliu, A., & Aguilera, A. (2025). Transcription‐Replication Conflicts: Unlocking New Frontiers in Cancer. BioEssays, 47(8). https://doi.org/10.1002/bies.70025
Vancouver
Bayona-Feliu A, Aguilera A. Transcription‐Replication Conflicts: Unlocking New Frontiers in Cancer. BioEssays. 2025;47(8). doi:10.1002/bies.70025
BibTeX
@article{BayonaFeliu2025,
author = {Bayona-Feliu, Aleix and Aguilera, Andrés},
title = {Transcription‐Replication Conflicts: Unlocking New Frontiers in Cancer},
journal = {BioEssays},
year = {2025},
volume = {47},
number = {8},
doi = {10.1002/bies.70025}
}
EUVIMED